Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma (Q40233559)
Jump to navigation
Jump to search
scientific article published on March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma |
scientific article published on March 2007 |
Statements
1 reference
Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma (English)
1 reference
Bernard Escudier
1 reference
Nathalie Lassau
1 reference
Jean Charles Soria
1 reference
Linda Chami
1 reference
Eric Zafarana
1 reference
Veronique Landreau
1 reference
Eric Brendel
1 reference
Jean-Pierre Armand
1 reference
1 March 2007
1 reference
1 reference
13
1 reference
6
1 reference
1801-1809
1 reference
Identifiers
1 reference
1 reference